Publications
484 publications
- Date
- Relevance
-
Alhydran (BAP Medical BV) hydrating creams for burns, radiodermatitis and hand-foot syndrome
Alhydran (or other hydrating (scar) creams) does not comply with established medical science and medical practice and is ...
-
Deep Brain Stimulation in patients with therapy-resistant obsessive-compulsive disorder
In the Netherlands this treatment is combined with cognitive behavioural therapy. This report is a summary of recommendations by ...
-
Diabetes Package Scan
In a package scan we analyse the adequacy and accessibility of the package of insured care for a particular disease. Does the ...
-
Rivaroxaban (Xarelto) for the indication 'treatment of pulmonary embolism'
The WAR has approved a pharmacotherapeutic report for the medicine rivaroxaban (Xarelto®) 15 mg tablet for oral use. In ...
-
Catumaxomab (Removab) for the indication ‘malignant ascites’
The most important effect of catumaxomab in clinical research is a statistically significant 35-day extension in ‘puncture-free ...
-
Tapentadol (Palexia Retard) for the indication severe chronic pain
The therapeutic value of tapentadol for the treatment of severe chronic pain in adults who can only be treated with opioid ...
-
Mirabegron (Betmiga) for the indication overactive bladder syndrome
The WAR approved the pharmacotherapeutic report of the medicine mirabegron (Betmiga). Its therapeutic value was determined via ...
-
Coronary Heart Disease Package Scan
In a package scan we analyse the adequacy and accessibility of the package of insured care for a particular disease. Does the ...
-
Intestinal transplant
The National Health Care Institute concludes that intestinal transplants in patients with intestinal failure who have persistent ...
-
Depression Package Scan
In 2009 there were 555,000 people suffering from depression in the Netherlands. The degree to which people with a depression ...